Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

DIRECT-SAFE: A Randomized Controlled Trial of DIRECT Endovascular Clot Retrieval Versus Standard Bridging Thrombolysis With Endovascular Clot Retrieval Within 4.5 Hours of Stroke Onset

NCT03494920 is registered in ClinicalTrials.gov with Neuroscience Trials Australia as lead sponsor.

NCT NCT03494920
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03494920 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
DIRECT-SAFE: A Randomized Controlled Trial of DIRECT Endovascular Clot Retrieval Versus Standard Bridging Thrombolysis With Endovascular Clot Retrieval Within 4.5 Hours of Stroke Onset
Lead sponsor
Neuroscience Trials Australia
Phase
Phase 3
Overall status
Completed
Start date
April 27, 2018
Completion date
September 8, 2021
Enrollment
295 (actual)
Sites
33

Conditions

As the registry lists them; a condition with its own page is linked.

ischemic stroke